Sexual dimorphism in colon cancer

M Abancens, V Bustos, H Harvey, J McBryan… - Frontiers in …, 2020‏ - frontiersin.org
A higher incidence of colorectal cancer (CRC) is found in males compared to females.
Young women (18–44 years) with CRC have a better survival outcome compared to men of …

Estrogen receptor alpha and beta in health and disease

M Jia, K Dahlman-Wright, JÅ Gustafsson - Best practice & research Clinical …, 2015‏ - Elsevier
Estrogen receptors alpha (ERα) and beta (ERβ) are transcription factors that are involved in
the regulation of many complex physiological processes in humans. Abnormal ER signaling …

Insufficient antibody validation challenges oestrogen receptor beta research

S Andersson, M Sundberg, N Pristovsek… - Nature …, 2017‏ - nature.com
The discovery of oestrogen receptor β (ERβ/ESR2) was a landmark discovery. Its reported
expression and homology with breast cancer pharmacological target ERα (ESR1) raised …

Molecular pathways: estrogen pathway in colorectal cancer

A Barzi, AM Lenz, MJ Labonte, HJ Lenz - Clinical cancer research, 2013‏ - aacrjournals.org
Worldwide, colorectal cancer has a higher incidence rate in men than in women, suggesting
a protective role for sex hormones in the development of the disease. Preclinical data …

Estrogen receptors and their implications in colorectal carcinogenesis

F Caiazza, EJ Ryan, G Doherty, DC Winter… - Frontiers in …, 2015‏ - frontiersin.org
Upon binding their cognate receptors, ERα (ESR1) and ERβ (ESR2), estrogens activate
intracellular signaling cascades that have important consequences for cellular behavior …

Pathway analysis of genomic data: concepts, methods, and prospects for future development

VK Ramanan, L Shen, JH Moore, AJ Saykin - TRENDS in Genetics, 2012‏ - cell.com
Genome-wide data sets are increasingly being used to identify biological pathways and
networks underlying complex diseases. In particular, analyzing genomic data through sets …

Colitis‐induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity

A Ibrahim, LW Hugerth, L Hases… - … journal of cancer, 2019‏ - Wiley Online Library
Chronic inflammation of the colon (colitis) is a risk factor for colorectal cancer (CRC).
Hormone‐replacement therapy reduces CRC incidences, and the estrogen receptor beta …

Estrogen receptor beta as target for colorectal cancer prevention

C Williams, A DiLeo, Y Niv, JÅ Gustafsson - Cancer letters, 2016‏ - Elsevier
Colorectal cancer (CRC) is a leading cause of death in the United States. Despite its slow
development and the capacity for early diagnosis, current preventive approaches are not …

The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches

N Zafari, F Khosravi, Z Rezaee… - Journal of Clinical …, 2022‏ - Wiley Online Library
Background Colorectal cancer (CRC) with a high prevalence is recognized as the fourth
most common cause of cancer‐related death globally. Over the past decade, there has been …

[HTML][HTML] Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome

Q Wei, P Guo, K Mu, Y Zhang, W Zhao, W Huai… - Laboratory …, 2015‏ - Elsevier
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. The
incidence of HCC is strikingly higher in males than in females. The remarkable gender …